The cost of influenza-associated hospitalizations and outpatient visits in Kenya
Authors:
- Gideon O. EmukuleGEGideon O. Emukule
- Linus K. NdegwaLNLinus K. Ndegwa
- Michael L. WashingtonMWMichael L. Washington
- John W. PagetJohn W. Paget
- Jazmin DuqueJDJazmin Duque
- Sandra S. ChavesSCSandra S. Chaves
- Nancy A. OtienoNONancy A. Otieno
- Kabura WamburuKWKabura Wamburu
- Irene W. NdigirigiINIrene W. Ndigirigi
- Philip M. MuthokaPMPhilip M. Muthoka
- Koos van der VeldenKVKoos van der Velden
- Joshua A. MottJMJoshua A. Mott
Open Access
- 10 May 2019
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 19 (S3) , 1-10
Abstract
We estimated the cost-per-episode and the annual economic burden associated with influenza in Kenya. From July 2013–August 2014, we recruited patients with severe acute respiratory illness (SARI) or influenza-like illness (ILI) associated with laboratory-confirmed influenza from 5 health facilities. A structured questionnaire was used to collect direct costs (medications, laboratory investigations, hospital bed fees, hospital management costs, transportation) and indirect costs (productivity losses) associated with an episode of influenza. We used published incidence of laboratory-confirmed influenza associated with SARI and ILI, and the national population census data from 2014, to estimate the annual national number of influenza-associated hospitalizations and outpatient visits and calculated the annual economic burden by multiplying cases by the mean cost. We enrolled 275 patients (105 inpatients and 170 outpatients). The mean cost-per-episode of influenza was US$117.86 (standard deviation [SD], 88.04) among inpatients; US$114.25 (SD, 90.03) for children < 5 years, and US$137.45 (SD, 76.24) for persons aged ≥5 years. Among outpatients, the mean cost-per-episode of influenza was US$19.82 (SD, 27.29); US$21.49 (SD, 31.42) for children < 5 years, and US$16.79 (SD, 17.30) for persons aged ≥5 years. National annual influenza-associated cost estimates ranged from US$2.96–5.37 million for inpatients and US$5.96–26.35 million for outpatients. Our findings highlight influenza as causing substantial economic burden in Kenya. Further studies may be warranted to assess the potential benefit of targeted influenza vaccination strategies.,Keywords
This publication has 17 references indexed in Scilit:
- The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and KenyaMalaria Journal, 2013
- Estimation of the National Disease Burden of Influenza-Associated Severe Acute Respiratory Illness in Kenya and Guatemala: A Novel MethodologyPLOS ONE, 2013
- The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong KongVaccine, 2012
- Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009BMC Infectious Diseases, 2011
- Healthcare-seeking Behaviour for Common Infectious Disease-related Illnesses in Rural Kenya: A Community-based House-to-house SurveyJournal of Health, Population and Nutrition, 2011
- The Burden of Common Infectious Disease Syndromes at the Clinic and Household Level from Population-Based Surveillance in Rural and Urban KenyaPLOS ONE, 2011
- High costs of influenza: Direct medical costs of influenza disease in young childrenVaccine, 2010
- The annual impact of seasonal influenza in the US: Measuring disease burden and costsVaccine, 2007
- Economic burden and absenteeism from influenza-like illness in healthy households with children (5–17 years) in the USRespiratory Medicine, 2007
- The cost of influenza in ThailandVaccine, 2006